Centro Clinico Nemo

Milan 20162

3 studies enrolling now · 11 studies all time

What they study most

ALS, Amyotrophic Lateral Sclerosis, Becker Muscular Dystrophy, CDM, Congenital Myotonic Dystrophy, DM1, Duchenne Muscular Dystrophy, Facioscapulohumeral Muscular Dystrophy, Myotonic Dystrophy 1, Myotonic Dystrophy Type 1 (DM1)

Studies at this site

• Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) — Recruiting now
• DMCRN-02-001: Assessing Pediatric Endpoints in DM1 — Recruiting now
• A Phase 1/2 Study of VX-670 in Adult Participants With Myotonic Dystrophy 1 (DM1) — Recruiting now
• Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1 — Recruiting now
• Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD — Running, not enrolling
• Trial Readiness and Endpoint Assessment in Congenital Myotonic Dystrophy — Completed
• Phase 3 Trial of Pamrevlumab or Placebo in Combination With Systemic Corticosteroids in Participants With Ambulatory DMD — Stopped early
• Phase III Trial of AMX0035 for Amyotrophic Lateral Sclerosis Treatment — Running, not enrolling
• Becker Muscular Dystrophy - A Natural History Study to Predict Efficacy of Exon Skipping — Status unconfirmed
• Comparative Study of Clinical Endpoint in DMD: Handheld Myometry (HHM) Versus CINRG Quantitative Measurement System (CQMS) — Completed
• Talampanel for Amyotrophic Lateral Sclerosis (ALS) — Completed